Free Trial
→ With the “Bitcoin Loophole” you can help supercharge the gains by 10x or more! (From DTI) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 9 of 15

Slide 9
Back to 8
Continue to 10
 
Back to 8
Continue to 10
 

Arcellx (NASDAQ:ACLX)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
14 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$103.08 (2.9% Upside)

About Arcellx

Arcellx logoArcellx, Inc, together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/12/2024Truist FinancialBoost Price TargetBuy ➝ Buy$87.00 ➝ $136.00
11/8/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$91.00 ➝ $115.00
11/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$96.00 ➝ $96.00
11/6/2024HC WainwrightBoost Price TargetBuy ➝ Buy$80.00 ➝ $95.00
11/6/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$77.00 ➝ $106.00
11/6/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$84.00 ➝ $100.00
11/6/2024Morgan StanleyBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $106.00
10/31/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$96.00 ➝ $96.00
10/18/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$81.00 ➝ $96.00
10/18/2024Stifel NicolausBoost Price TargetBuy ➝ Buy$83.00 ➝ $122.00
Slide 9
Back to 8
Continue to 10
 

Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

More From MarketBeat
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
20 Stocks to Sell Now
Most people know that Wall Street analyst recommendations are overstated because of pressure from public compa...
MarketBeat
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
7 Consumer Discretionary Stocks That Will Continue to Rally
Consumer discretionary stocks appear to be among the winners from the ongoing Trump trade following the U.S. p...
MarketBeat
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
7 Dividend Stocks to Buy Under $20
On September 18, 2024, the Federal Reserve dropped its federal funds rate by 50 basis points (0.5%). Furthermo...
MarketBeat